ORCHARD THERAPEUTICS PLC - ADS (ORTX) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2018 to Q3 2023

Type / Class
Equity / ADS
Symbol
ORTX
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of ORCHARD THERAPEUTICS PLC - ADS (ORTX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2023 Q3 0 $0 -$10,637,101 0
2023 Q2 2,041,670 $10,637,101 +$10,637,101 $5.21 1
2023 Q1 0 $0 -$16,300,331 0
2022 Q4 43,945,075 $16,300,331 -$1,968,426 $0.37 44
2022 Q3 49,339,300 $24,669,763 -$1,795,549 $0.50 40
2022 Q2 51,750,635 $30,229,912 -$1,964,525 $0.58 46
2022 Q1 54,639,404 $38,905,281 -$8,718,148 $0.71 54
2021 Q4 64,105,605 $84,617,462 -$22,407,661 $1.32 64
2021 Q3 72,702,106 $167,332,379 -$27,031,423 $2.30 75
2021 Q2 79,900,342 $350,733,708 +$4,771,666 $4.39 79
2021 Q1 65,725,764 $477,169,275 +$139,556,444 $7.26 79
2020 Q4 47,611,446 $205,700,230 -$21,911,284 $4.32 73
2020 Q3 64,703,196 $266,126,763 -$23,507,852 $4.11 68
2020 Q2 57,712,585 $346,277,150 +$3,512,775 $6.00 75
2020 Q1 56,652,537 $426,590,471 -$29,641,078 $7.53 71
2019 Q4 65,068,146 $894,695,899 +$23,526,621 $13.75 80
2019 Q3 63,580,566 $755,335,412 +$29,422,375 $11.88 60
2019 Q2 60,602,881 $847,828,543 +$162,400,816 $13.99 68
2019 Q1 48,952,943 $875,283,000 +$7,721,751 $17.88 43
2018 Q4 48,633,101 $764,997,000 +$764,997,000 $15.73 36